Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- PMID: 30078514
- DOI: 10.1016/j.kint.2018.04.011
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Abstract
The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079- 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316-300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743-1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073-37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.
Keywords: CKD burden; DALYs; age; chronic kidney disease; death; diabetes; epidemiology; global health; glomerulonephritis; hypertension; incidence; population; prevalence.
Published by Elsevier Inc.
Comment in
-
Getting to know the enemy better-the global burden of chronic kidney disease.Kidney Int. 2018 Sep;94(3):462-464. doi: 10.1016/j.kint.2018.05.009. Epub 2018 Aug 3. Kidney Int. 2018. PMID: 30078513
Similar articles
-
Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.JAMA Netw Open. 2018 Nov 2;1(7):e184412. doi: 10.1001/jamanetworkopen.2018.4412. JAMA Netw Open. 2018. PMID: 30646390 Free PMC article.
-
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study.Diabetes Obes Metab. 2025 Apr;27(4):1902-1919. doi: 10.1111/dom.16183. Epub 2025 Jan 13. Diabetes Obes Metab. 2025. PMID: 39806549
-
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13. Lancet. 2020. PMID: 32061315 Free PMC article.
-
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.Glob Heart. 2014 Mar;9(1):145-158.e21. doi: 10.1016/j.gheart.2013.12.008. Glob Heart. 2014. PMID: 25432124 Review.
-
Global burden of disease in young people aged 10-24 years: a systematic analysis.Lancet. 2011 Jun 18;377(9783):2093-102. doi: 10.1016/S0140-6736(11)60512-6. Epub 2011 Jun 7. Lancet. 2011. PMID: 21652063 Review.
Cited by
-
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population.Nutrients. 2022 Sep 14;14(18):3787. doi: 10.3390/nu14183787. Nutrients. 2022. PMID: 36145162 Free PMC article. Review.
-
A senolysis-based theragnostic prodrug strategy towards chronic renal failure.Chem Sci. 2022 Sep 26;13(40):11738-11745. doi: 10.1039/d2sc03525a. eCollection 2022 Oct 19. Chem Sci. 2022. PMID: 36320912 Free PMC article.
-
Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings.Kidney Int Rep. 2022 Jul 16;7(10):2141-2149. doi: 10.1016/j.ekir.2022.07.002. eCollection 2022 Oct. Kidney Int Rep. 2022. PMID: 36217525 Free PMC article.
-
Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular Stiffness.J Clin Med. 2023 Nov 29;12(23):7384. doi: 10.3390/jcm12237384. J Clin Med. 2023. PMID: 38068435 Free PMC article.
-
Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States.Front Public Health. 2022 Sep 6;10:999848. doi: 10.3389/fpubh.2022.999848. eCollection 2022. Front Public Health. 2022. PMID: 36159316 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical